Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


The Fertility Show


 

Book Review: Gene Jockeys - Life Science and the Rise of Biotech Enterprise

24 November 2014

By Dr Ross Cloney

Appeared in BioNews 781

Gene Jockeys: Life Science and the Rise of Biotech Enterprise

By Professor Nicolas Rasmussen

Published by Johns Hopkins University Press

ISBN-10: 142141340X, ISBN-13: 978-1421413402

Buy this book from Amazon UK


'Everybody has the same damn list.'

It was with these words that Peter Farley, one-time president of the biotechnology firm, Cetus, described the early days of commercial molecular biology. This race to clone, express and commercialise human genes is the focus of Nicolas Rasmussen's book 'Gene Jockeys', named after the half-insult/half-compliment used to describe the scientists driving the merger of science and commercialism.

Rasmussen maintains a careful balance between the science behind the rise of commercial biotechnology and the personalities driving it. Unfortunately, there are moments when the repeated description of the same fundamental techniques – cDNA synthesis, cloning, and gene expression – gets repetitive without delving deeper into biology behind them.

In a similar manner, since the rush to achieve scientific and commercial success was centered on the same list of 'low-hanging fruit' being worked on by a handful of researchers, the same names repeatedly crop up - but I failed to gain any understanding of the personalities beyond all of them being motivated, driven scientists.

As someone who trained in molecular biology laboratories, I enjoyed Rasmussen's perspective on how far the field has come over the last 40 years. In the late 1970s and early 1980s, techniques now routinely given to undergraduates were the cutting edge. It is an unspoken statement about how quickly the field has advanced and matured.

What also struck me is how little demand there was for the early products. The existing drug and pharmaceutical firms were already providing the medical establishment with the insulin, human growth hormone, etc. that it required. In a nice inverse of established rhetoric, the science drove the market and not the other way around. It was only because insulin and other hormones were so well studied and understood biologically that they could be cloned and commercialised.

Rasmussen successfully explores the landscape beyond the science, carefully highlighting the cultural changes that occurred during the rise of biotech. Against a background of tightening research budgets and dwindling job opportunities for highly skilled postdocs in academia, the companies of Genentech and its competitors are portrayed as 'postdoc republics'.

While commercial entities, the initial days preserved a lot of the informal hierarchy and 'traditions' of academic work – particularly in regards to the sharing of materials. Indeed, the scientific rewards of being the first to clone a particular gene were treated as important as the commercial rewards. As the field matured and the realities of patent protection and clinical trials became evident, this initial holdover of academic culture ebbed. The founding biotech companies evolved into firms not dissimilar from the large pharmaceutical enterprises they initially challenged.

'Gene Jockeys' is not a guide to cloning or a biography of the key people involved in developing commercial biotechnology. It is, however, an excellent insight into the change from academia to industry, a shift in values and practices that is as common today as it was in the early 1980s.


Buy Gene Jockeys: Life Science and the Rise of Biotech Enterprise from Amazon UK.

SOURCES & REFERENCES

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

10 March 2014 - by Ari Haque 
As part of the British Library's TalkScience season, a panel of eminent speakers to discussed the role of patents in biomedicine...
07 January 2013 - by Dr Peter Mills 
How valuable are emerging biotechnologies? Of all the questions about the prospects of the life sciences, this is the one that UK policy makers seem most eager to answer...
18 June 2012 - by Dr Martin Turner and Dr Ian Turner 
By exploring the legislative history and case law of patents both in Europe and the US, Oliver Mills asks why morality has become such a pervasive issue and whether European law in its current state is fit for purpose...
01 August 2011 - by Dr Amy Strange 
'Biotechnology and Cloning' is part of a series of educational books for teenagers addressing 'contemporary social issues'. It is an unusual concept, being neither a textbook nor a revision guide. It does not directly explain the underlying science, but outlines and encourages the reader to think around the topics....
20 June 2011 - by Stevienna de Saille 
Arising from Dr Antoinette Rouvroy's doctoral research, Human Genes and Neoliberal Governance was originally published as a hardback in 2008, but has only recently become available in a paperback edition affordable to the general reader. In between those two dates much has happened in the field of genetics and governance, both globally and in the UK...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Moving the Boundaries of Human Reproduction

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Jacques Cohen

Dr Anna Smajdor

Dr Andy Greenfield

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation